Clinical Trial Update: Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on subretinal transplantation of retinal pigment epitheliums for dry age-related macular degeneration (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Dry Age-related Macular Degeneration

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Dry Age-related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN